INO
Inovio Pharmaceuticals Inc
1.20$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +62.3% | -18.8% | +7.8% | -30.0% | +9.8% | +275.0% | -8.1% | -29.7% | -51.0% | -33.8% | -34.4% | |
| – | +73.7% | -27.5% | +11.0% | -36.5% | +7.3% | +400.2% | -4.8% | -29.7% | -51.4% | -36.1% | -37.5% | |
| – | +42.1% | -66.8% | +24.3% | -0.4% | -6.3% | +1,029.6% | -71.6% | -34.9% | -69.1% | +359.9% | -32.7% | |
| – | +74.1% | -35.7% | +21.6% | -36.3% | +10.2% | +359.8% | -2.5% | -37.0% | -42.6% | -35.2% | -37.8% | |
| – | +161.5% | +126.0% | -60.8% | -37.5% | -49.9% | +838.1% | -57.9% | +46.1% | -79.5% | -50.1% | -100.0% | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | +59.4% | +23.5% | +103.0% | -12.9% | -19.9% | -11.2% | +53.8% | -55.7% | – | – | – | |
| – | +0.0% | +4.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -100.0% | – | – | |
| – | -18.2% | +95.3% | -21.2% | -20.8% | -22.4% | -14.8% | -16.5% | -18.9% | – | – | – | |
| – | +87.2% | +32.8% | -11.1% | -1.5% | +214.3% | -43.2% | +22.4% | +31.1% | -57.5% | -16.6% | +12.4% | |
| – | +123.4% | +39.3% | -19.2% | -0.3% | -9.4% | +30.4% | +57.6% | +47.3% | -56.1% | -17.0% | +23.6% | |
| – | +84.0% | +74.3% | +23.0% | – | – | +12.3% | +11.8% | +7.7% | +583.9% | -87.0% | +13.0% | |
| – | +119.4% | +56.9% | +21.4% | +29.8% | -30.6% | -80.8% | +1,804.9% | -24.6% | -78.0% | +38.6% | -59.3% | |
| – | – | – | – | – | – | -75.8% | -19.8% | +11.1% | – | – | – | |
| – | +58.0% | -29.8% | +15.5% | -38.9% | -96.0% | +13,324.4% | -13.3% | -44.4% | -47.2% | -41.6% | -64.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +15.1% | +7.1% | +11.9% | +13.0% | +6.7% | +57.1% | +34.6% | +14.3% | +11.5% | +22.5% | +72.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.